Qiwen Pan

Qiwen Pan

Auto-generated profile, based on publicly available information

Qiwen Pan

State Key Laboratory of Luminescent Materials and Devices Guangdong Provincial Key Laboratory of Fiber Laser Materials and Applied Techniques School of Materials Science and Engineering South China University of Technology Guangzhou 510640 China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2019 in Advanced Optical Materials
Verified
Journal Article
Closed access
PDF file
QPQiwen Pan
Qiwen Pan
ZCZhenlu Cai
Zhenlu Cai
YYYerong Yang
Yerong Yang
DYDandan Yang
Dandan Yang
SKShiliang Kang
Shiliang Kang
GDGuoping Dong
Guoping Dong

1 January 2020 in Medicine
Verified
Journal Article
Open access
XTXinmei Tan
Xinmei Tan
QPQiwen Pan
Qiwen Pan
CMChanggan Mo
Changgan Mo
XLXianshu Li
Xianshu Li
XLXueyan Liang
Xueyan Liang
LCLingyuan Chen
Lingyuan Chen
Background: Complicated urinary tract infections (cUTI) are universal reasons for hospitalization, and highly likely to develop into sepsis or septic shock. Carbapenem antibiotics with potentially higher efficacy or with fewer and milder side effects have increased in popularity, but evidence is limited by a scarcity of randomized controlled trials (RCTs) comparing different carbapenem antibiotics for cUTI. Network meta-analysis is a useful tool to compare multiple treatments when there is limited or no direct evidence available. Objective: The aim of this study is to compare the efficacy and safety of different carbapenems with alternative antibiotics for the treatment of cUTI. Methods: Pubmed, Medline, CENTRAL, and Embase were searched in November 2018. Studies of cUTI patients receiving carbapenem were included. We performed network meta-analysis to estimate the risk ratio (RR) and 95% credible interval (CrI) from both direct and indirect evidence; traditional meta-analysis was also performed. Primary outcomes were clinical and microbiological treatment success. Results: A total of 19 studies and 7380 patients were included in the analysis. Doripenem (DOPM) was associated with lower clinical treatment success rates than other carbapenems. Although the efficacy of other carbapenems by RRs with 95% CrIs did not show statistical differences, the cumulative rank probability indicated that meropenem/vaborbactam (MV), ertapenem (ETPM), and biapenem (BAPM) had higher clinical and microbiological treatment success rates; imipenem/cilastatin (IC) and MV showed higher risk of adverse events (AEs). Conclusions: MV was associated with higher treatment success rates for cUTI, especially for cUTI caused by carbapenem-resistant uropathogens, but also with higher risk of AEs. Our findings suggest MV as a first-choice treatment of carbapenem-resistant cUTI. ETPM, BAPM, and meropenem (MEPM) is another reasonable choice for cUTI empiric therapy.

24 February 2014 in Chempluschem
Verified
Journal Article
Closed access
PDF file
GDGuoping Dong
Guoping Dong
HHHuilin He
Huilin He
QPQiwen Pan
Qiwen Pan
GCGengxu Chen
Gengxu Chen
JXJunhua Xie
Junhua Xie
MPMingying Peng
Mingying Peng

1 September 2013 in Materials Express
Verified
Journal Article
Closed access
DYDandan Yang
Dandan Yang
GZGuiyun Zhao
Guiyun Zhao
QPQiwen Pan
Qiwen Pan
MLMinru Liang
Minru Liang
ZMZhijun Ma
Zhijun Ma
JQJianrong Qiu
Jianrong Qiu
ZnAl2O4 nanofibers and nanoparticles were in situ synthesized by electrospinning technique. Utilizing poly (vinyl pyrrolidone) (PVP) with different degree of polymerization, SEM (scanning electron microscope) results indicate that ZnAl2O4 nanostructures exhibit different morphologies under the same electrospun parameters. When PVP with high molecular weight (Mw = 1,300,000) was used, the ultra-long ZnAl2O4 nanofibers were obtained with an average diameter of ∼200 nm. However, while PVP with low molecular weight (K-30) was used, the ZnAl2O4 changed into particle-shape with an average size of ∼100 nm. Utilizing Nd3+ ions as the optical activator, three emission peaks centered at 905 nm, 1064 nm and 1335 nm were detected respectively in the photoluminescence (PL) spectra of ZnAl2O4:Nd3+ nanostructures under 808 nm laser excitation. It is noticed that both the excitation wavelength (808 nm) and the emission wavelength (905 nm and 1064 nm) are located in the 700–1100 nm optical window of cells and tissues. And the cytotoxicity investigation indicates ZnAl2O4:Nd3+ nanostructures are biocompatible with human cells, which endow their potential application as biological mark-ers, etc.

10 December 2020 in Advanced Photonics Research
Verified
Journal Article
Open access
PDF file
QCQinpeng Chen
Qinpeng Chen
ZCZhenlu Cai
Zhenlu Cai
QPQiwen Pan
Qiwen Pan
GDGuoping Dong
Guoping Dong
To improve the utilization efficiency of chlorophyll to sunlight, Tm3+/Cr3+ codoped dual‐phase glass‐ceramics are successfully fabricated as a dual‐light conversion material by the conventional melt‐quenching technique with subsequent heat treatment. Exploiting the radius difference in atomic size, Tm3+ and Cr3+ ions have been rationally designed entering into the NaYF4 and NaAlSiO4 crystal phase, respectively, to avoid detrimental energy quenching. The resulted dual‐phase glass‐ceramics exhibit a great emission enhancement compared to the precursor glass. No obvious lifetime degradation in the codoped glass‐ceramic further proves the successful incorporation of Tm3+ and Cr3+ in distinguished crystalline phases. Utilizing the dual‐phase glass‐ceramics, the useless sunlight can be converted into the desired red/blue region and reabsorbed by the chlorophyll. The Tm3+ ions convert ultraviolet light into the blue region, and the Cr3+ ions transfer green light to the red emission. With the utilization of Tm3+/Cr3+ codoped dual‐phase glass‐ceramics in the greenhouse, the photosynthesis process can be promoted, and furthermore, the production of crops can be improved, indicating the potential applications in the field of green agriculture.